PRQR
PRQR
NASDAQ · Biotechnology

Proqr Therapeutics Nv

$1.62
+0.11 (+7.28%)
As of Mar 31, 10:09 PM ET ·
Day Range $1.51 — $1.66
52W Range $1.07 — $3.10
Open$1.52
Previous Close$1.51
Day High$1.66
Day Low$1.51
52W High$3.10
52W Low$1.07
Volume
Avg Volume275.1K
Market Cap154.82M
P/E Ratio
EPS$-0.40
SectorBiotechnology

Analyst Ratings

Strong Buy
15 analysts
14 Buy 1 Hold 0 Sell
Price Target +467.9% upside
Current
$1.62
Target
$9.20
$6.27 $9.20 avg $10.38

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 17.54M 11.66M 53.79M
Net Income -45,258,707 -27,074,002 2.31M
Profit Margin -258.1% -245.2% 4.3%
EBITDA -44,094,750 -27,843,145 4.13M
Free Cash Flow 1.88M
Rev Growth +50.5% +50.5% +4.8%
Debt/Equity 0.32 0.32 0.17

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $214.98 -1.15% 166.6 397.77B
AMGN Amgen Inc $353.28 +0.41% 24.7 190.40B
GILD Gilead Sciences Inc $140.30 +0.67% 19.6 166.66B
VRTX Vertex Pharmaceuticals Inc $447.26 +0.16% 29.1 114.87B
REGN Regeneron Pharmaceuticals $777.25 +0.60% 17.9 80.50B
ALNY Alnylam Pharmaceuticals Inc $330.03 -0.25% 139.7 43.84B

PRQR News

No news for PRQR yet

Quick Stats

Market Cap154.82M
P/E Ratio
EPS$-0.40
Volume
SectorBiotechnology